home / stock / crdf / crdf quote
Last: | $5.47 |
---|---|
Change Percent: | -4.87% |
Open: | $5.73 |
Close: | $5.75 |
High: | $5.73 |
Low: | $5.25 |
Volume: | 387,205 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.47 | $5.73 | $5.75 | $5.73 | $5.25 | 387,205 | 03-28-2024 |
$5.75 | $5.44 | $5.75 | $5.76 | $5.31 | 1,764,969 | 03-27-2024 |
$5.39 | $5.91 | $5.39 | $6.05 | $5.32 | 1,449,028 | 03-26-2024 |
$5.91 | $6.05 | $5.91 | $6.42 | $5.62 | 1,971,677 | 03-25-2024 |
$5.85 | $5.13 | $5.85 | $6.11 | $5.01 | 2,737,034 | 03-22-2024 |
$5.14 | $5.03 | $5.14 | $5.2999 | $4.7811 | 795,514 | 03-21-2024 |
$4.96 | $4.85 | $4.96 | $5.2299 | $4.7 | 938,833 | 03-20-2024 |
$4.87 | $5.08 | $4.87 | $5.15 | $4.7107 | 707,779 | 03-19-2024 |
$5.17 | $5.09 | $5.17 | $5.4 | $4.2 | 1,828,925 | 03-18-2024 |
$5.03 | $5.4 | $5.03 | $5.63 | $4.61 | 2,013,644 | 03-15-2024 |
$5.4 | $5.5 | $5.4 | $6.06 | $5.1 | 2,978,459 | 03-14-2024 |
$5.4 | $4.63 | $5.4 | $5.85 | $4.5001 | 3,967,089 | 03-13-2024 |
$4.48 | $4.02 | $4.48 | $4.59 | $4 | 1,471,281 | 03-12-2024 |
$4.04 | $4.22 | $4.04 | $4.36 | $3.7801 | 2,167,861 | 03-11-2024 |
$4.14 | $3.55 | $4.14 | $4.18 | $3.55 | 1,835,858 | 03-08-2024 |
$3.51 | $3.95 | $3.51 | $4.12 | $3.32 | 2,034,281 | 03-07-2024 |
$3.89 | $3.85 | $3.89 | $4.11 | $3.56 | 2,703,857 | 03-06-2024 |
$3.65 | $3.55 | $3.65 | $3.84 | $3.18 | 2,847,391 | 03-05-2024 |
$3.49 | $2.97 | $3.49 | $3.85 | $2.96 | 12,883,824 | 03-04-2024 |
$2.91 | $2 | $2.91 | $3.07 | $2 | 45,135,566 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cardiff Oncology Inc. Company Name:
CRDF Stock Symbol:
NASDAQ Market:
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhib...
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced publications of five abstracts that will be presented in a poster session at...
U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the N...